Nuvalent, Inc.

NASDAQ:NUVL

102.16 (USD) • At close October 17, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Revenue 00000
Cost of Revenue 00000
Gross Profit 00000
Gross Profit Ratio 00000
Reseach & Development Expenses 113.24363.73135.55915.4039.746
General & Administrative Expenses 36.24922.37710.2581.5020.612
Selling & Marketing Expenses 36.2130000
SG&A 36.24922.37710.2581.5020.612
Other Expenses 04.254-0.5212.349-1.451
Operating Expenses 139.38286.10845.81716.90510.358
Operating Income -149.492-86.108-45.817-16.905-10.358
Operating Income Ratio 00000
Total Other Income Expenses Net 23.2734.254-0.5212.349-1.451
Income Before Tax -126.219-81.854-46.338-14.556-11.809
Income Before Tax Ratio 00000
Income Tax Expense -0.168-8.508-0.237-0.017-0.01
Net Income -126.219-73.346-46.338-14.556-11.809
Net Income Ratio 00000
EPS -2.17-1.48-0.96-0.3-0.24
EPS Diluted -2.17-1.48-0.96-0.3-0.24
EBITDA -149.492-86.108-45.817-16.905-10.358
EBITDA Ratio 00000